Jaroslav Bublevič

Immune Markers in Non-Small Cell Lung Cancer: What Else Beyond Pd-L1 and Tumour Mutational Burden is there?

S. Cicėnas, Y. Shimizu, V. Pašukonienė, 2019, Biomedical Journal of Scientific & Technical Research.

Significance of blood serum catalase activity and malondialdehyde level for survival prognosis of ovarian cancer patients.

J. Didziapetriene, G. Smailytė, R. Stukas, 2014, Medicina.

The role of genetic and other biomarkers in NSCLC prognosis

S. Cicėnas, J. Didziapetriene, V. Šapoka, 2014 .

Relationship of MDA Plasma Concentrations to Long-term Survival of Breast Cancer Patients

J. Didziapetriene, G. Smailytė, V. Kasiulevičius, 2014, Tumori.

Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding

T. Žvirblis, K. Suziedelis, E. Aleknavičius, 2017, BMC Cancer.